Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2009

Nov 13, 2009

34975_dirs_2009-11-13_da434bdb-23a1-4d87-9a70-3c10d7557c16.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2009-11-12

Reporting Person: LUSCINSKI SUSAN M (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-11-12 Common Stock, per value $0.01 per share M 98550 $1.0462 Acquired 221507 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-11-12 Stock Option (right to buy) $1.0462 M 98550 Disposed 2010-01-01 Common Stock, par value $0.01 per share (98550) Direct